Shock In COVID-19: Types, Triggers, And Treatments Differ, But ...

Skip to main content News Daily News Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

In a sign of the viral disease’s varied effects, distributive shock outnumbered cardiogenic and few cases were tied to acute MI.

By Caitlin E. Cox

• Created with Sketch.

November 24, 2021

One in eight patients hospitalized with COVID-19 develop some form of shock, according to the American Heart Association’s COVID-19 Cardiovascular Disease Registry.

And regardless of whether the shock type is cardiogenic, distributive, or a mixture of the two, mortality rates are extremely high: around two-thirds of those with the condition die.

Investigator Anubodh S. Varshney, MD (Brigham and Women’s Hospital, Harvard Medical School, Boston, MA), said the study emerged out of his experience working in a COVID intensive care unit in the early days of the pandemic. As awareness of the disease’s cardiac manifestations grew, clinicians began to notice patients were developing severe forms of shock.

“Some of it was more-conventional septic shock, which we’re used to seeing in the context of infections, but increasingly we were seeing more and more patients have cardiogenic shock and cardiac failure in the context of their COVID,” he told TCTMD. “There was clearly a need to characterize these patients and try to identify who’s more at risk . . . and also try to shed some light on how we as a country are treating those entities.”

The best strategy to decrease risk of cardiogenic shock with COVID-19 remains vaccination, and this is especially important for patients with a history of heart disease. Anubodh S. Varshney

The data set, with a “broad swath” of hospitals, sheds light on what’s been going on around the United States, noted Varshney.

Notably, many of the shock cases weren’t related specifically to an acute MI, he observed. “In a lot of cases it could be more of a right ventricular predominant shock due to [acute respiratory distress syndrome] happening at the same time. It could be related to pulmonary hypertension acutely coming on. Or it could be related to myocarditis or stress cardiomyopathies.

Varshney led the study along with Wally A. Omar, MD (Beth Israel Deaconess Medical Center, Harvard Medical School, Boston). The results were published last week as a research letter in Circulation: Heart Failure.

Less Than 1% Cardiogenic

Varshney, Omar, and colleagues analyzed 15,208 COVID-19 admissions at 104 hospitals that occurred between January 14 and September 20, 2020. Most of the hospitals (58%) had fewer than 500 beds, 96% were urban, and 85% were teaching sites.

Patients developed some sort of shock in 12% of these hospital stays, with only 0.7% being cardiogenic shock (CS). Another 9% had distributive shock (DS), 1% had mixed shock (MS; both cardiogenic and distributive), and 1% had other/unknown shock. These rates were similar when excluding patients with preexisting heart failure.

In absolute numbers, the data set contained 105 admissions for cardiogenic, 1,409 for distributive, and 159 for mixed shock.

Patients with CS were more likely to have a prior MI, coronary revascularization, and heart failure than those with no shock or DS. At admission, the cardiogenic group more often had abnormal chest imaging and elevated levels of troponin, D-dimer, C-reactive protein, and natriuretic peptide compared with the distributive and mixed groups; they also were less likely to show pulmonary infectious signs and symptoms.

Among those who underwent echocardiography, 28% of patients with CS had LVEF < 30%. Just 6% of patients without shock had such low ejection fraction.

Management strategies were, naturally, influenced by the presence of shock. Regardless of shock type, nearly all were given inotropes/vasopressors and were on mechanical ventilation. Venovenous extracorporeal membrane oxygenation (VV ECMO) was infrequent with shock, but still more commonly used than in patients without shock. Yet few of the shock patients, even those with CS, underwent angiography or PCI, and few received mechanical circulatory support (MCS) in the form of intra-aortic balloon pump (IABP), percutaneous ventricular assist device (PVAD), or venoarterial ECMO (VA ECMO).

Treatment by Shock Type in Hospitalized COVID-19 Patients

	CS	DS	MS	None
Inotropes/Vasopressors	94%	99%	100%	0
Mechanical Ventilation	90%	89%	92%	10%
VV ECMO	8%	3%	3%	0.2%
MCS      IABP     PVAD     VA ECMO	11% 7% 6% 0	0.4% 0 0.2% 0.2%	4% 1.3% 1.3% 1.3%	0 0 0 0
Coronary Angiography     ≥ 1 Obstructive Lesion	10% 56%	0.3% 33%	2% 100%	0.4% 68%
PCI	8%	0.1%	0.6%	0.2%

While hospitalized, 77% of patients with CS, 64% of those with DS, and 78% those with MS experienced death, cardiac arrest, acute MI, or stroke. Among those without shock, the rate of this composite endpoint was 13%.

Mortality was highest with MS, at 69%, followed by 63% with CS, 57% with DS, and 10% in the absence of shock. Respiratory causes for death predominated in the mixed, distributed, and no shock groups at 68%, 78%, and 73%. For patients with CS, 48% of deaths were due to respiratory causes and 32% to cardiovascular causes (with 20% due to “other” reasons).

The death rates for shock patients mirror a those of a recent analysis from the North American COVID-19 Myocardial Infarction (NACMI) registry, which focused on STEMI patients who received mechanical circulatory support.

Here, the population was much more broad.

“Despite a high prevalence of cardiovascular risk factors and cardiovascular disease in patients with CS or MS, only ˜20% had acute myocardial infarction during hospitalization (inclusive of demand-related events),” the paper notes. “This is consistent with growing evidence implicating mechanisms of cardiac involvement in COVID-19 beyond acute coronary syndromes, including stress-induced cardiomyopathy, inflammatory myocarditis, microvascular dysfunction and thrombosis, and decompensation of underlying heart failure.”

Varshney emphasized that the study is observational, making it difficult to draw lessons to apply in clinical practice. That said, it does make an argument for getting a COVID-19 shot. “I do think the one big message is we always say an ounce of prevention is worth a pound of cure,” he stressed. “The best strategy to decrease risk of cardiogenic shock with COVID-19 remains vaccination, and this is especially important for patients with a history of heart disease.”

Going forward, he said, it will be important to investigate a number of nuances within the AHA data, including temporal changes in how patients were managed and how they fared, as well as any between-hospital variations.

by Caitlin E. Cox

Caitlin E. Cox is News Editor of TCTMD and Associate Director, Editorial Content at the Cardiovascular Research Foundation. She produces the…

Read Full Bio

• Created with Sketch.

• Sources
• Disclosures
• Comments

Sources

• Varshney AS, Omar WA, Goodrich EL, et al. Epidemiology of cardiogenic shock in hospitalized adults with COVID-19: a report from the American Heart Association COVID-19 Cardiovascular Disease Registry. Circ Heart Fail. 2021;14:e008477.

Disclosures

• The AHA suite of registries is funded by multiple industry sponsors. AHA’s COVID-19 Cardiovascular Disease Registry is partially supported by the Gordon and Betty Moore Foundation.
• Varshney is on the advisory board for Broadview Ventures and is supported by a National Heart, Lung, and Blood Institute postdoctoral training grant as well as the Daniel Pierce Family Fellowship in Advanced Heart Disease.
• Omar reports no relevant conflicts of interest.

Comments

Log in to post comments. COVID-19 Clinical Cardiology Coronary Hemodynamic Support Public Health

Related News

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

News Features

Mechanical Circulatory Support in COVID-19: Mixed Results, Hints of Hope

News Conference News TCT 2021

Cardiogenic Shock: SCAI Categories Get a Rethink as Research Rolls On

Never Miss a Beat

Stay up-to-date with breaking news, conference slides, and topical videos covering the spectrum of CVD. Join our newsletter!

Advertisement

Top Content

Video Interview

SCAI SHOCK Update

November 5, 2021 Presentation TCT 2021

Featured Lecture: The SCAI SHOCK Classification Update - Rationale and Modifications

News Daily News

COVID-19: TCTMD’s Dispatch for September 26

Advertisement

Sign In

New at TCTMD? Register today!

Email Address Password

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Email Address

Search TCTMD

Search Content Type Video Slides News Conference Member Cases Podcasts Partner Content Manuscripts More Type Options Topic Clinical Cardiology Coronary Endovascular Heart Failure Heart Rhythm Imaging Policy & Practice Structural Heart Year Conference Sort By relevancy By date Matching Exact phrase Include all of these words Include some of these words cme

CME TITLE

First Name Last Name Degree Select a Degree MD DO PA PhD RN LPN NP Other Email Institution If other, please specify AREA OF CLINICAL INTEREST Address Address 2 (Optional) City State Zip Country Select a Country United States United Kingdom Australia Canada France New Zealand India Brazil Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Cape Verde Cayman Islands Central African Republic Chad Chile China Colombia Comoros Democratic Republic of the Congo Republic of the Congo Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Fiji Finland Gabon Gambia Georgia Germany Ghana Gibraltar Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati North Korea South Korea Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Curacao Nicaragua Niger Nigeria Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Romania Russia Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands, British Virgin Islands, U.S. Yemen Zambia Zimbabwe Submit a Question for the Panel (Optional)

Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

First Name Last Name Email Profession - Select -PhysicianIndustryAllied HealthOther Organization Address Country - Select -AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua & BarbudaArgentinaArmeniaArubaAscension IslandAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia & HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCanary IslandsCape VerdeCaribbean NetherlandsCayman IslandsCentral African RepublicCeuta & MelillaChadChileChinaChristmas IslandClipperton IslandCocos (Keeling) IslandsColombiaComorosCongo - BrazzavilleCongo - KinshasaCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d’IvoireDenmarkDiego GarciaDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard & McDonald IslandsHondurasHong Kong SAR ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao SAR ChinaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalNetherlandsNetherlands AntillesNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorthern Mariana IslandsNorth KoreaNorth MacedoniaNorwayOmanOutlying OceaniaPakistanPalauPalestinian TerritoriesPanamaPapua New GuineaParaguayPeruPhilippinesPitcairn IslandsPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSamoaSan MarinoSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia & South Sandwich IslandsSouth KoreaSouth SudanSpainSri LankaSt. BarthélemySt. HelenaSt. Kitts & NevisSt. LuciaSt. MartinSt. Pierre & MiquelonSt. Vincent & GrenadinesSudanSurinameSvalbard & Jan MayenSwedenSwitzerlandSyriaSão Tomé & PríncipeTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad & TobagoTristan da CunhaTunisiaTurkeyTurkmenistanTurks & Caicos IslandsTuvaluU.S. Outlying IslandsU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVatican CityVenezuelaVietnamWallis & FutunaWestern SaharaYemenZambiaZimbabweÅland Islands CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Leave this field blank Close Popup

Main navigation

• News
  • Conference News
  • Features
  • Opinion
• Conferences
• Slides
• Specialties
  • COVID-19
  • Clinical
  • Coronary
  • Structural
  • Endovascular
  • Heart Failure
  • Heart Rhythm
  • Imaging & Physiology
  • Policy & Practice
• Podcasts
  • Heart Sounds
  • Rox Heart Radio
  • TCTMD Talking Points
  • Taking It To Heart
  • Heart Valve Matters
• Videos
  • All Videos
  • Interviews
  • Topical Discussions
  • On Record
  • Live Cases
  • Partner Content
• Fellows Forum
• CV Team Forum

Top User Menu

• CME
• Register
• Login

Search TCTMD

Search Close Search

Submit an Event

Contact Email Contact Phone Number Event Name Location Start Date Start Time End Date End Time Event Description < >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim